How to: Antiarrhythmika in der klinischen Anwendung

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

How to: Antiarrhythmika in der klinischen Anwendung. / Hillmann, Henrike A.K.; Betz, Konstanze; Linz, Dominik; Duncker, David.

In: Herzschrittmachertherapie und Elektrophysiologie, Vol. 34, 2023, p. 82–90.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Hillmann, HAK, Betz, K, Linz, D & Duncker, D 2023, 'How to: Antiarrhythmika in der klinischen Anwendung', Herzschrittmachertherapie und Elektrophysiologie, vol. 34, pp. 82–90. https://doi.org/10.1007/s00399-022-00919-y

APA

Hillmann, H. A. K., Betz, K., Linz, D., & Duncker, D. (2023). How to: Antiarrhythmika in der klinischen Anwendung. Herzschrittmachertherapie und Elektrophysiologie, 34, 82–90. https://doi.org/10.1007/s00399-022-00919-y

Vancouver

Hillmann HAK, Betz K, Linz D, Duncker D. How to: Antiarrhythmika in der klinischen Anwendung. Herzschrittmachertherapie und Elektrophysiologie. 2023;34:82–90. https://doi.org/10.1007/s00399-022-00919-y

Author

Hillmann, Henrike A.K. ; Betz, Konstanze ; Linz, Dominik ; Duncker, David. / How to: Antiarrhythmika in der klinischen Anwendung. In: Herzschrittmachertherapie und Elektrophysiologie. 2023 ; Vol. 34. pp. 82–90.

Bibtex

@article{f5d96f8b129c4f55af9c4c95d5a15060,
title = "How to: Antiarrhythmika in der klinischen Anwendung",
abstract = "Antiarrhythmic drugs are important for the noninvasive rhythm control therapy of heart rhythm disorders. Antiarrhythmic drugs, which can be categorized into subgroups based on their different effects on ion channels, are clinically used for various types of arrhythmias. Knowledge about these specific electrophysiological effects contributes to a better understanding in order to select the correct drug for each specific arrhythmia. This review summarizes mechanisms, indications, contraindications, and side effects of the different antiarrhythmic drugs and, thus, supports their adequate use in daily clinical routine.",
keywords = "Atrial fibrillation, Drug therapy, Rhythm control, Supraventricular tachycardias, Ventricular tachycardias",
author = "Hillmann, {Henrike A.K.} and Konstanze Betz and Dominik Linz and David Duncker",
note = "Publisher Copyright: {\textcopyright} 2023, The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.",
year = "2023",
doi = "10.1007/s00399-022-00919-y",
language = "Tysk",
volume = "34",
pages = "82–90",
journal = "Herzschrittmachertherapie und Elektrophysiologie",
issn = "0938-7412",
publisher = "D. Steinkopff-Verlag",

}

RIS

TY - JOUR

T1 - How to: Antiarrhythmika in der klinischen Anwendung

AU - Hillmann, Henrike A.K.

AU - Betz, Konstanze

AU - Linz, Dominik

AU - Duncker, David

N1 - Publisher Copyright: © 2023, The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

PY - 2023

Y1 - 2023

N2 - Antiarrhythmic drugs are important for the noninvasive rhythm control therapy of heart rhythm disorders. Antiarrhythmic drugs, which can be categorized into subgroups based on their different effects on ion channels, are clinically used for various types of arrhythmias. Knowledge about these specific electrophysiological effects contributes to a better understanding in order to select the correct drug for each specific arrhythmia. This review summarizes mechanisms, indications, contraindications, and side effects of the different antiarrhythmic drugs and, thus, supports their adequate use in daily clinical routine.

AB - Antiarrhythmic drugs are important for the noninvasive rhythm control therapy of heart rhythm disorders. Antiarrhythmic drugs, which can be categorized into subgroups based on their different effects on ion channels, are clinically used for various types of arrhythmias. Knowledge about these specific electrophysiological effects contributes to a better understanding in order to select the correct drug for each specific arrhythmia. This review summarizes mechanisms, indications, contraindications, and side effects of the different antiarrhythmic drugs and, thus, supports their adequate use in daily clinical routine.

KW - Atrial fibrillation

KW - Drug therapy

KW - Rhythm control

KW - Supraventricular tachycardias

KW - Ventricular tachycardias

UR - http://www.scopus.com/inward/record.url?scp=85146761333&partnerID=8YFLogxK

U2 - 10.1007/s00399-022-00919-y

DO - 10.1007/s00399-022-00919-y

M3 - Tidsskriftartikel

C2 - 36692540

AN - SCOPUS:85146761333

VL - 34

SP - 82

EP - 90

JO - Herzschrittmachertherapie und Elektrophysiologie

JF - Herzschrittmachertherapie und Elektrophysiologie

SN - 0938-7412

ER -

ID: 334856847